MB, Levis & Associates’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.36K | Hold |
806
| – | – | ﹤0.01% | 248 |
|
|
2025
Q1 | $1.64K | Hold |
806
| – | – | ﹤0.01% | 254 |
|
|
2024
Q4 | $2.65K | Hold |
806
| – | – | ﹤0.01% | 252 |
|
|
2024
Q3 | $2.22K | Hold |
806
| – | – | ﹤0.01% | 256 |
|
|
2024
Q2 | $3.28K | Hold |
806
| – | – | ﹤0.01% | 238 |
|
|
2024
Q1 | $5.39K | Hold |
806
| – | – | ﹤0.01% | 214 |
|
|
2023
Q4 | $3.79K | Hold |
806
| – | – | ﹤0.01% | 225 |
|
|
2023
Q3 | $3.36K | Hold |
806
| – | – | ﹤0.01% | 229 |
|
|
2023
Q2 | $2.54K | Buy |
+806
| New | +$2.54K | ﹤0.01% | 243 |
|